Key Insights

Highlights

Treatment Research

11 treatments under study, led by Busulfan

Related Conditions

Often studied with 13 related conditions

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

50.0%

1 terminated out of 2 trials

Success Rate

0.0%

-86.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

0

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Unknown1
Terminated1

Clinical Trials (2)

Showing 2 of 2 trials
NCT00006054Not ApplicableTerminated

Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies

NCT00006056Not ApplicableUnknown

Pilot Study of Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients With Life Threatening Hemophagocytic Disorders

Showing all 2 trials

Research Network

Common Treatments

  • Busulfan2
  • Etoposide2
  • Cyclophosphamide2
  • Methotrexate2
  • Antithymocyte Globulin2

Active Sponsors

  • Fairview University Medical Center2

Top Investigators

Related Conditions

  • Hemophagocytic Lymphohistiocytosis2
  • Chediakhigashi Syndrome2
  • Graft Versus Host Disease2
  • Virusassociated Hemophagocytic Syndrome2
  • Xlinked Lymphoproliferative Syndrome2

Activity Timeline